Sandoz Inc Company Profile
What is the competitive landscape for SANDOZ INC
SANDOZ INC has twenty-two approved drugs.
There are twenty-three tentative approvals on SANDOZ INC drugs.
Summary for Sandoz Inc
| US Patents: | 0 |
| Tradenames: | 16 |
| Ingredients: | 15 |
| NDAs: | 22 |
| Patent Litigation for Sandoz Inc: | See patent lawsuits for Sandoz Inc |
| PTAB Cases with Sandoz Inc as petitioner: | See PTAB cases with Sandoz Inc as petitioner |
Drugs and US Patents for Sandoz Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz Inc | ROPINIROLE HYDROCHLORIDE | ropinirole hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201047-004 | Jun 6, 2012 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sandoz Inc | AMOXICILLIN AND CLAVULANATE POTASSIUM | amoxicillin; clavulanate potassium | TABLET;ORAL | 065117-001 | Nov 27, 2002 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Sandoz Inc | ALPRAZOLAM | alprazolam | TABLET, EXTENDED RELEASE;ORAL | 077777-002 | Jun 30, 2006 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Sandoz Inc | OLANZAPINE | olanzapine | POWDER;INTRAMUSCULAR | 201588-001 | Oct 24, 2011 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sandoz Inc | CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INJECTION | 065204-002 | May 3, 2005 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Sandoz Inc | CISATRACURIUM BESYLATE | cisatracurium besylate | INJECTABLE;INJECTION | 200159-001 | Feb 3, 2012 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sandoz Inc | CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INJECTION | 065204-001 | May 3, 2005 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
